000 01455 a2200373 4500
005 20250517004114.0
264 0 _c20150821
008 201508s 0 0 eng d
022 _a1873-2364
024 7 _a10.1016/j.nmd.2014.08.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aOkada, Akinori
245 0 0 _aEfficacy of intravenous immunoglobulin for treatment of Lambert-Eaton myasthenic syndrome without anti-presynaptic P/Q-type voltage-gated calcium channel antibodies: a case report.
_h[electronic resource]
260 _bNeuromuscular disorders : NMD
_cJan 2015
300 _a70-2 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Intravenous
650 0 4 _aAdult
650 0 4 _aAutoantibodies
650 0 4 _aCalcium Channels, P-Type
_xblood
650 0 4 _aCalcium Channels, Q-Type
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulins, Intravenous
_xadministration & dosage
650 0 4 _aLambert-Eaton Myasthenic Syndrome
_xdiagnosis
650 0 4 _aMuscle, Skeletal
_xphysiopathology
650 0 4 _aTreatment Outcome
700 1 _aKoike, Haruki
700 1 _aNakamura, Tomohiko
700 1 _aMotomura, Masakatu
700 1 _aSobue, Gen
773 0 _tNeuromuscular disorders : NMD
_gvol. 25
_gno. 1
_gp. 70-2
856 4 0 _uhttps://doi.org/10.1016/j.nmd.2014.08.006
_zAvailable from publisher's website
999 _c24399066
_d24399066